Treatment of High-Risk Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia in Adolescents and Adults According to Early Cytologic Response and Minimal Residual Disease After Consolidation Assessed by Flow Cytometry: Final Results of the PETHEMA ALL-AR-03 Trial Journal of Clinical Oncology , Vol.
http://ift.tt/1qa1Snx
http://ift.tt/1qa1Snx
No comments:
Post a Comment